Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
22.47B | 22.39B | 21.20B | 19.68B | 18.31B | 22.36B | Gross Profit |
3.06B | 2.51B | 2.95B | 3.02B | 2.26B | 3.21B | EBIT |
130.97M | -422.04M | 68.33M | 257.10M | -515.55M | 163.49M | EBITDA |
1.21B | 639.88M | 874.49M | 1.23B | 339.03M | 2.02B | Net Income Common Stockholders |
172.13M | -305.54M | -73.83M | 307.54M | -1.03B | 268.98M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.19B | 4.46B | 3.38B | 3.86B | 3.29B | 3.57B | Total Assets |
24.19B | 24.77B | 23.50B | 23.04B | 21.99B | 22.88B | Total Debt |
6.37B | 6.60B | 5.63B | 5.38B | 5.07B | 4.36B | Net Debt |
3.38B | 2.34B | 2.46B | 1.73B | 1.98B | 988.98M | Total Liabilities |
13.06B | 13.75B | 12.44B | 12.27B | 11.79B | 11.73B | Stockholders Equity |
11.13B | 11.02B | 11.07B | 10.78B | 10.20B | 11.15B |
Cash Flow | Free Cash Flow | ||||
0.00 | -334.18M | -413.35M | -71.62M | -938.16M | 469.60M | Operating Cash Flow |
0.00 | 560.31M | 685.54M | 661.24M | 446.46M | 1.81B | Investing Cash Flow |
0.00 | -409.17M | -1.12B | -148.12M | -1.25B | -693.15M | Financing Cash Flow |
0.00 | 811.15M | -192.51M | -82.88M | 555.28M | -371.98M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥3.65B | 8.37 | 3.53% | -8.73% | -41.93% | ||
70 Outperform | ¥3.73B | 15.71 | 4.36% | 9.25% | -45.40% | ||
68 Neutral | ¥2.83B | 7.93 | 3.25% | 0.23% | -16.37% | ||
66 Neutral | ¥3.57B | 7.89 | 4.90% | 3.82% | ― | ||
62 Neutral | $6.83B | 11.28 | 2.95% | 3.88% | 2.70% | -24.56% | |
60 Neutral | ¥3.41B | 10.35 | ― | -3.39% | ― | ||
39 Underperform | ¥3.68B | ― | ― | 33.86% | 69.12% |